
Fixbase T 250mg/31.25mg Injection
Marketer
Cagrus Biopharma
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Fixbase T 250mg/31.25mg Injection
Combiflox T Injection (250mg/31.25mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby controlling infection spread. Administration of Combiflox T Injection must always be under a doctor's guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, even with symptom improvement. Premature cessation may reduce its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects warrant immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) require prompt emergency care. Inform your physician about all current medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and sufficient hydration will support recovery. Your doctor might request lab tests to monitor the medicine's impact.
Primary Ingredients of Fixbase T 250mg/31.25mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Fixbase T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Fixbase T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Fixbase T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Fixbase T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Fixbase T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactum injection (Fixbase T 250mg/31.25mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to survive. Tazobactum counters bacterial resistance, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Fixbase T 250mg/31.25mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
Fixbase T 250mg/31.25mg Injection is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Fixbase T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Fixbase T 250mg/31.25mg Injection can induce drowsiness, visual disturbances, and dizziness. Operating a vehicle is contraindicated if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Fixbase T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Fixbase T 250mg/31.25mg requires careful administration for individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the dosage of Fixbase T 250mg/31.25mg Injection is unnecessary for patients exhibiting mild or moderately compromised liver function.
What if you forget to take Fixbase T 250mg/31.25mg Injection :
Omit a Fixbase T 250mg/31.25mg Injection dose? Seek your physician's advice.
Facts to Know About Fixbase T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
